{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:23:01Z","timestamp":1790482981716,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01DA005018"],"award-info":[{"award-number":["R01DA005018"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["F32DA063281"],"award-info":[{"award-number":["F32DA063281"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["F32DA057804"],"award-info":[{"award-number":["F32DA057804"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["T32DA031115"],"award-info":[{"award-number":["T32DA031115"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["L70DA061529"],"award-info":[{"award-number":["L70DA061529"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008635","name":"University of Texas Health Science Center at San Antonio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA031115"],"award-info":[{"award-number":["T32DA031115"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F32DA063281"],"award-info":[{"award-number":["F32DA063281"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA005018"],"award-info":[{"award-number":["R01DA005018"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AQ-0039"],"award-info":[{"award-number":["AQ-0039"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpet.2025.103671","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T06:06:15Z","timestamp":1753682775000},"page":"103671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of \u03949-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC:CBD mixtures on behavioral and physiological signs of morphine withdrawal in rhesus monkeys"],"prefix":"10.1016","volume":"392","author":[{"given":"Lawrence M.","family":"Carey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8672-8323","authenticated-orcid":false,"given":"Lindsey K.","family":"Galbo-Thomma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-5397","authenticated-orcid":false,"given":"David R.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5157-6307","authenticated-orcid":false,"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103671_bib1","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2022 National Survey on Drug Use and Health","year":"2023"},{"issue":"11","key":"10.1016\/j.jpet.2025.103671_bib2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1360-0443.1994.tb03745.x","article-title":"Opiate withdrawal","volume":"89","author":"Farrell","year":"1994","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jpet.2025.103671_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.jpet.2025.103671_bib4","series-title":"Oxford Handbook of Opioids and Opioid Use Disorder","first-page":"194","article-title":"The opioid withdrawal syndrome: presentation, measurement, and management","author":"Dunn","year":"2023"},{"key":"10.1016\/j.jpet.2025.103671_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2017.02.020","article-title":"A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal","volume":"176","author":"Gorodetzky","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jpet.2025.103671_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.prcp.20180006","article-title":"Pharmacological and behavioral treatment of opioid use disorder","volume":"1","author":"Sofuoglu","year":"2019","journal-title":"Psychiatr Res Clin Pract"},{"key":"10.1016\/j.jpet.2025.103671_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","article-title":"Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes","volume":"52","author":"Bentzley","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.jpet.2025.103671_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/add.15998","article-title":"The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment","volume":"118","author":"Glanz","year":"2023","journal-title":"Addiction"},{"issue":"10182","key":"10.1016\/j.jpet.2025.103671_bib9","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.jpet.2025.103671_bib10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","article-title":"Barriers and facilitators to the use of medications for opioid use disorder: a rapid review","volume":"35","author":"Mackey","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpet.2025.103671_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2013.04.034","article-title":"Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal","volume":"248","author":"Scavone","year":"2013","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.jpet.2025.103671_bib12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1124\/jpet.119.258004","article-title":"Non-opioid neurotransmitter systems that contribute to the opioid withdrawal syndrome: a review of preclinical and human evidence","volume":"371","author":"Dunn","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103671_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109702","article-title":"Alleviation of opioid withdrawal by cannabis and \u03949-tetrahydrocannabinol: a systematic review of observational and experimental human studies","volume":"241","author":"De Aquino","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jpet.2025.103671_bib14","first-page":"65","article-title":"Analgesic, heart rate, and temperature effects of \u03948-THC during acute and chronic administration to conscious rats","volume":"15","author":"Hine","year":"1977","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103671_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00426828","article-title":"Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice","volume":"49","author":"Bhargava","year":"1976","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103671_bib16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29469-6","article-title":"Opioid and cannabinoid modulation of precipitated withdrawal in \u03949-tetrahydrocannabinol and morphine-dependent mice","volume":"298","author":"Lichtman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2025.103671_bib17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/jpet.102.046870","article-title":"Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral \u03949-tetrahydrocannabinol","volume":"305","author":"Cichewicz","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103671_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.05.013","article-title":"The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","volume":"154","author":"Bisaga","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103671_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugalcdep.2014.11.015","article-title":"Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice","volume":"146","author":"Gamage","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103671_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2016.05.002","article-title":"Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans","volume":"164","author":"Lofwall","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.jpet.2025.103671_bib21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0024-3205(75)90435-X","article-title":"Interactions between cannabidiol and \u03949-THC during abstinence in morphine-dependent rats","volume":"17","author":"Hine","year":"1975","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jpet.2025.103671_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13150","article-title":"CBD-mediated regulation of heroin withdrawal-induced behavioural and molecular changes in mice","volume":"27","author":"Navarrete","year":"2022","journal-title":"Addict Biol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103671_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/can.2022.0036","article-title":"Cannabidiol reduced the severity of gastrointestinal symptoms of opioid withdrawal in male and female mice","volume":"9","author":"Scicluna","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpet.2025.103671_bib24","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2010"},{"issue":"3","key":"10.1016\/j.jpet.2025.103671_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-008-1293-6","article-title":"Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys","volume":"201","author":"Becker","year":"2008","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2025.103671_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/jpet.115.231381","article-title":"Combined treatment with morphine and \u03949-tetrahydrocannabinol in rhesus monkeys: antinociceptive tolerance and withdrawal","volume":"357","author":"Gerak","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2025.103671_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"19","key":"10.1016\/j.jpet.2025.103671_bib28","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1007\/s00213-015-4023-x","article-title":"Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys","volume":"232","author":"Gerak","year":"2015","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jpet.2025.103671_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1360-0443.2003.00372.x","article-title":"Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans","volume":"98","author":"Walsh","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jpet.2025.103671_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0163-7258(02)00258-9","article-title":"Cardiovascular effects of cannabinoids","volume":"95","author":"Randall","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpet.2025.103671_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugalcdep.2015.09.031","article-title":"Safety of oral dronabinol during opioid withdrawal in humans","volume":"157","author":"Jicha","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.jpet.2025.103671_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.1983.179","article-title":"Metabolism, disposition, and kinetics of \u03949-tetrahydrocannabinol in men and women","volume":"34","author":"Wall","year":"1983","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jpet.2025.103671_bib33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1476-5381.1977.tb07721.x","article-title":"Cardiovascular effects of \u03949-tetrahydrocannabinol in conscious and anaesthetized dogs","volume":"59","author":"Friedman","year":"1977","journal-title":"Br J Pharmacol"},{"issue":"11-12","key":"10.1016\/j.jpet.2025.103671_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12012-023-09810-9","article-title":"\u03949-tetrahydrocannabinol effects on respiration and heart rate across route of administration in female and male mice","volume":"23","author":"Laudermilk","year":"2023","journal-title":"Cardiovasc Toxicol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103671_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0361-9230(87)90087-6","article-title":"\u03949-Tetrahydrocannabinol: EEG changes, bradycardia and hypothermia in the rhesus monkey","volume":"19","author":"Matsuzaki","year":"1987","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.1016\/j.jpet.2025.103671_bib36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(24)37642-6","article-title":"Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A","volume":"286","author":"Vivian","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2025.103671_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3565(25)32409-2","article-title":"The cardiovascular and autonomic effects of repeated administration of \u03949-tetrahydrocannabinol to rhesus monkeys","volume":"216","author":"Fredericks","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103671_bib38","first-page":"147","article-title":"Clonidine and the primate locus coeruleus: evidence suggesting anxiolytic and anti-withdrawal effects","volume":"71","author":"Redmond","year":"1981","journal-title":"Prog Clin Biol Res"},{"issue":"6 Pt 2","key":"10.1016\/j.jpet.2025.103671_bib39","first-page":"25","article-title":"The primate locus coeruleus and effects of clonidine on opiate withdrawal","volume":"43","author":"Redmond","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpet.2025.103671_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lfs.2017.11.029","article-title":"Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects","volume":"192","author":"Mendiguren","year":"2018","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103671_bib41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1476-5381.2010.00776.x","article-title":"How important are sex differences in cannabinoid action?","volume":"160","author":"Fattore","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103671_bib42","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1111\/bcp.16218","article-title":"Sex differences in comorbid pain and opioid use disorder: a scoping review","volume":"90","author":"DeVito","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpet.2025.103671_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108005","article-title":"The impact of naturalistic cannabis use on self-reported opioid withdrawal","volume":"113","author":"Bergeria","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jpet.2025.103671_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugalcdep.2016.05.016","article-title":"Enhanced discriminative stimulus effects of \u03949-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys","volume":"165","author":"McMahon","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jpet.2025.103671_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41380-021-01299-4","article-title":"Cross-species anxiety tests in psychiatry: pitfalls and promises","volume":"27","author":"Bach","year":"2022","journal-title":"Mol Psychiatry"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:17:24Z","timestamp":1777943844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0022356525398848"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103671","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of \u03949-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC:CBD mixtures on behavioral and physiological signs of morphine withdrawal in rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103671"}}